Search KEQU
KEWAUNEE SCIENTIFIC CORP /DE/
Nasdaq · CIK 55529
Last close34.16
Daily change+0.25 (0.74%)
10 Years gain+57.50%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
KEQU · STANDARD
SIC 3821 · Laboratory Apparatus & Furniture · Fiscal year end 0430
Fundamental
61.7Momentum
45.4Acceleration
40.3Confidence
90.0Annual Revenue18
Quarterly Revenue69
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.6 / 25
Quality20.7 / 25
Capital Efficiency7.9 / 20
Balance Sheet9.2 / 15
Shareholder Economics6.2 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.4109 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.4708%.
Warnings
ROIC declining · MEDIUMROIC declined by 3.4471 percentage points.
Key Metrics
Revenue Growth TTM31.8%OK
Revenue CAGR 3Y8.71%OK
Gross Margin28.47%OK
Operating Margin5.29%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC12.52%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.47%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Apr 30, 2026 | $282.00M | $80.44M | $16.72M | $18.63M | $14.70M | 28.52% | 5.93% | 5.21% | 14.81% | 2.98M |
| 2026 FY Apr 30, 2025 | $240.47M | $68.86M | $17.76M | $14.78M | $12.62M | 28.63% | 7.39% | 5.25% | 22.85% | 2.98M |
| 2025 FY Apr 30, 2024 | $203.76M | $52.05M | $18.28M | $19.56M | $15.19M | 25.55% | 8.97% | 7.46% | 35.2% | 2.94M |
| 2024 FY Apr 30, 2023 | $219.49M | $35.59M | $5.36M | -$3.79M | -$7.94M | 16.21% | 2.44% | -3.62% | 10.6% | 2.9M |
| 2023 FY Apr 30, 2022 | $168.87M | $24.22M | -$2.61M | -$7.89M | -$9.79M | 14.34% | -1.54% | -5.8% | -5.44% | 2.79M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $276.92M | sum latest 4 fiscal quarters Revenue | OK | 0000055529-26-000035, 0000055529-25-000054 |
| Revenue Growth TTM | 31.8% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000055529-26-000035, 0000055529-25-000054 |
| Revenue CAGR 3Y | 8.71% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000055529-26-000020 |
| Revenue CAGR 5Y | 13.84% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000055529-26-000020 |
| Gross Profit CAGR 3Y | 31.24% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000055529-26-000020 |
| Operating Income Growth | 12.19% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000055529-26-000035, 0000055529-25-000054 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 28.47% | Gross Profit / Revenue | OK | 0000055529-26-000035, 0000055529-25-000054 |
| Operating Margin | 5.29% | Operating Income / Revenue | OK | 0000055529-26-000035, 0000055529-25-000054 |
| ROIC | 12.52% | NOPAT / Average Invested Capital | OK | 0000055529-26-000035, 0000055529-25-000054 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000055529-26-000035 |
| Current Ratio | 2.2x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.44x | (Cash + Short-term Investments) / Total Debt | OK | 0000055529-26-000035 |
| Revenue per Diluted Share | $94.80 | Revenue / Diluted Shares | OK | 0000055529-26-000035, 0000055529-25-000054 |